Enterprise Value
51.2M
Cash
14.89M
Avg Qtr Burn
-4.759M
Short % of Float
3.57%
Insider Ownership
86.12%
Institutional Own.
1.91%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AgenT-797 Details Virus-Induced Acute Respiratory Disease Syndrome | Phase 1/2 Update | |
AgenT-797 Details Solid tumor/s, Testicular cancer, Non-small cell lung carcinoma, Cancer, Gastric cancer | Phase 1/2 Initiation |